ACAD
27.53
-2.47
-8.23%
AEMD
5.07
-0.03
-0.59%
APRI
0.48
+0.01
+2.13%
ARNA
1.58
-0.04
-2.47%
ATEC
0.21
-0.02
-8.70%
CNAT
2.72
+0.04
+1.49%
CRXM
0.19
0.00
0.00%
CYTX
0.24
-0.03
-11.28%
DXCM
61.4
-1.68
-2.66%
GNMK
5.63
-0.07
-1.23%
HALO
9.9
-0.32
-3.13%
ILMN
134.97
+1.32
+0.99%
INNV
0.08
-0.01
-6.98%
INO
9.39
-0.97
-9.36%
ISCO
3.7
-0.03
-0.80%
ISIS
57.56
0.00
0.00%
LGND
120.39
+0.49
+0.41%
LPTN
0.226
-0.024
-9.7200%
MBVX
0.63
-0.03
-4.55%
MEIP
1.38
-0.04
-2.82%
MNOV
6.68
-0.16
-2.34%
MRTX
18.75
-1.46
-7.22%
MSTX
0.33
+0.011
+3.4169%
NBIX
42.91
-2.14
-4.75%
NUVA
52.64
+0.48
+0.92%
ONCS
1.72
-0.1
-5.49%
ONVO
2.61
-0.1
-3.69%
OREX
0.435
-0.027
-5.865%
OTIC
13.02
-0.82
-5.92%
QDEL
16.44
-0.48
-2.84%
RCPT
231.96
0.00
0.00%
RGLS
5.39
-0.05
-0.92%
RMD
56.03
+0.39
+0.70%
SPHS
1.35
-0.06
-4.26%
SRNE
6.75
-0.08
-1.17%
TROV
3.395
-0.355
-9.467%
VICL
0.373
-0.007
-1.7895%
VOLC
18
0.00
0.00%
ZGNX
9.91
-0.37
-3.60%
ACAD
27.53
-2.47
-8.23%
AEMD
5.07
-0.03
-0.59%
APRI
0.48
+0.01
+2.13%
ARNA
1.58
-0.04
-2.47%
ATEC
0.21
-0.02
-8.70%
CNAT
2.72
+0.04
+1.49%
CRXM
0.19
0.00
0.00%
CYTX
0.24
-0.03
-11.28%
DXCM
61.4
-1.68
-2.66%
GNMK
5.63
-0.07
-1.23%
HALO
9.9
-0.32
-3.13%
ILMN
134.97
+1.32
+0.99%
INNV
0.08
-0.01
-6.98%
INO
9.39
-0.97
-9.36%
ISCO
3.7
-0.03
-0.80%
ISIS
57.56
0.00
0.00%
LGND
120.39
+0.49
+0.41%
LPTN
0.226
-0.024
-9.7200%
MBVX
0.63
-0.03
-4.55%
MEIP
1.38
-0.04
-2.82%
MNOV
6.68
-0.16
-2.34%
MRTX
18.75
-1.46
-7.22%
MSTX
0.33
+0.011
+3.4169%
NBIX
42.91
-2.14
-4.75%
NUVA
52.64
+0.48
+0.92%
ONCS
1.72
-0.1
-5.49%
ONVO
2.61
-0.1
-3.69%
OREX
0.435
-0.027
-5.865%
OTIC
13.02
-0.82
-5.92%
QDEL
16.44
-0.48
-2.84%
RCPT
231.96
0.00
0.00%
RGLS
5.39
-0.05
-0.92%
RMD
56.03
+0.39
+0.70%
SPHS
1.35
-0.06
-4.26%
SRNE
6.75
-0.08
-1.17%
TROV
3.395
-0.355
-9.467%
VICL
0.373
-0.007
-1.7895%
VOLC
18
0.00
0.00%
ZGNX
9.91
-0.37
-3.60%
Home » Archive by Category

Diagnostics

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

August 26, 2011 – 9:57 am

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through …

SDBN August 16th 2011 Event Featuring Pathway Genomics

July 29, 2011 – 9:41 am

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for …